Benzinga

España
Italia
대한민국
日本
Français
Benzinga Edge
Benzinga Research
Benzinga Pro

  • Get Benzinga Pro
  • Data & APIs
  • Events
  • Premarket
  • Advertise
Contribute
España
Italia
대한민국
日本
Français

Benzinga

  • Premium Services
  • Financial News
    Latest
    Earnings
    Guidance
    Dividends
    M&A
    Buybacks
    Interviews
    Management
    Offerings
    IPOs
    Insider Trades
    Biotech/FDA
    Politics
    Healthcare
    Small-Cap
  • Markets
    Pre-Market
    After Hours
    Movers
    ETFs
    Options
    Cryptocurrency
    Commodities
    Bonds
    Futures
    Mining
    Real Estate
    Volatility
  • Ratings
    Analyst Color
    Downgrades
    Upgrades
    Initiations
    Price Target
  • Investing Ideas
    Trade Ideas
    Long Ideas
    Short Ideas
    Technicals
    Analyst Ratings
    Analyst Color
    Latest Rumors
    Whisper Index
    Stock of the Day
    Best Stocks & ETFs
    Best Penny Stocks
    Best S&P 500 ETFs
    Best Swing Trade Stocks
    Best Blue Chip Stocks
    Best High-Volume Penny Stocks
    Best Small Cap ETFs
    Best Stocks to Day Trade
    Best REITs
  • Money
    Investing
    Cryptocurrency
    Mortgage
    Insurance
    Yield
    Personal Finance
    Forex
    Startup Investing
    Real Estate Investing
    Prop Trading
    Credit Cards
    Stock Brokers
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
Unusual Options Activity Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Screeners
Stock Screener
Top Momentum Stocks
Top Quality Stocks
Top Value Stocks
Top Growth Stocks
Compare Best Stocks
Best Momentum Stocks
Best Quality Stocks
Best Value Stocks
Best Growth Stocks
Connect With Us
facebookinstagramlinkedintwitteryoutubeblueskymastodon
About Benzinga
  • About Us
  • Careers
  • Advertise
  • Contact Us
Market Resources
  • Advanced Stock Screener Tools
  • Options Trading Chain Analysis
  • Comprehensive Earnings Calendar
  • Dividend Investor Calendar and Alerts
  • Economic Calendar and Market Events
  • IPO Calendar and New Listings
  • Market Outlook and Analysis
  • Wall Street Analyst Ratings and Targets
Trading Tools & Education
  • Benzinga Pro Trading Platform
  • Options Trading Strategies and News
  • Stock Market Trading Ideas and Analysis
  • Technical Analysis Charts and Indicators
  • Fundamental Analysis and Valuation
  • Day Trading Guides and Strategies
  • Live Investor Events
  • Pre-market Stock Analysis and News
  • Cryptocurrency Market Analysis and News
Ring the Bell

A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.

  • Terms & Conditions
  • Do Not Sell My Personal Data/Privacy Policy
  • Disclaimer
  • Service Status
  • Sitemap
© 2026 Benzinga | All Rights Reserved
November 27, 2023 2:30 PM 3 min read

Crude Oil Falls; RedHill Biopharma Shares Spike Higher

by Lisa Levin Benzinga Editor
Follow

U.S. stocks traded mixed toward the end of trading on Monday.

The Dow traded down 0.13% to 35,344.56 while the NASDAQ rose 0.11% to 14,266.69. The S&P 500 also fell, dropping, 0.08% to 4,555.47.

Check This Out: IO Biotech And 2 Other Stocks Under $2 Insiders Are Buying

 

Leading and Lagging Sectors

 

Real estate shares rose by 0.5% on Monday.

In trading on Monday, energy shares fell by 1.1%.

 

Top Headline

 

U.S. new home sales declined by 5.6% to an annualized rate of 679,000 in October, compared to market estimates of 723,000.

 

Equities Trading UP

 

RedHill Biopharma Ltd. (NASDAQ:RDHL) shares shot up 214% to $0.99 after the company announced the FDA has granted five years' market exclusivity for Talicia.

Shares of Biodexa Pharmaceuticals Plc (NASDAQ:BDRX) got a boost, shooting 131% to $6.17 after the company announced it entered into agreements to acquire an exclusive worldwide license to tolimidone.

Asset Entities Inc. (NASDAQ:ASST) shares were also up, gaining 80% to $0.63 after the company announced a stock repurchase program allowing for the purchase of up to 1.25 million shares of its Class B common stock.

 

Equities Trading DOWN

 

Pagaya Technologies Ltd. (NASDAQ:PGY) shares dropped 5.5% to $1.2950 after the company said Michael Kurlander, Chief Financial Officer, has stepped down from his role to pursue an outside opportunity. The company named Deputy Chief Financial Officer Evangelos Perros as Interim Chief Financial Officer.

Shares of B. Riley Financial, Inc. (NASDAQ:RILY) were down 9% to $19.08 after gaining 8% on Friday. Impel Pharmaceuticals recently announced exploration of strategic alternatives.

Anavex Life Sciences Corp. (NASDAQ:AVXL) was down, falling 8% to $6.53 after the company reported fourth-quarter financial results.

Also Check This Out: Top 5 Consumer Stocks That Are Preparing To Pump This Quarter

 

Commodities

 

In commodity news, oil traded down 0.5% to $75.13 while gold traded up 0.5% at $2,013.50.

Silver traded up 1.4% to $24.685 on Monday while copper fell 0.7% to $3.7610.

 

Euro zone

 

European shares were lower today. The eurozone’s STOXX 600 fell 0.34%, London’s FTSE 100 fell 0.37% while Spain’s IBEX 35 Index fell 0.03% The German DAX fell 0.39% French CAC 40 slipped 0.37%, while Italy’s FTSE MIB Index fell 0.31%.

 

Asia Pacific Markets

 

Asian markets closed lower on Monday, with Japan’s Nikkei 225 falling 0.53%, Hong Kong’s Hang Seng Index falling 0.20% and China’s Shanghai Composite Index falling 0.30%. India’s S&P BSE Sensex, meanwhile, fell 0.1%.

Hong Kong’s trade deficit increased to $25.8 billion in October from $20.9 billion in the year-ago month. Profits earned by Chinese industrial firms fell by 7.8% year-over-year to CNY 6,115.42 billion in the first ten months of 2023, compared to a 9.0 % decline in the previous period.

 

Economics

 

U.S. new home sales declined by 5.6% to an annualized rate of 679,000 in October, compared to market estimates of 723,000.

Now Read This: Wall Street's Most Accurate Analysts Say Hold These 3 Health Care Stocks With Over 4% Dividend Yields

 

Market News and Data brought to you by Benzinga APIs

© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

To add Benzinga News as your preferred source on Google, click here.


Posted In:
EarningsNewsPenny StocksEurozoneCommoditiesSmall CapGlobalIntraday UpdateMarketsTrading Ideas
ASST Logo
ASSTStrive Inc
$8.04-0.12%
Overview
AVXL Logo
AVXLAnavex Life Sciences Corp
$3.95-2.23%
BDRX Logo
BDRXBiodexa Pharmaceuticals PLC
$1.22-2.40%
PGY Logo
PGYPagaya Technologies Ltd
$12.62-%
RDHL Logo
RDHLRedhill Biopharma Ltd
$1.044.00%
RILY Logo
RILYBRC Group Holdings Inc
$7.15-%
ASST Logo
ASSTStrive Inc
$8.04-0.12%
Overview
AVXL Logo
AVXLAnavex Life Sciences Corp
$3.95-2.23%
BDRX Logo
BDRXBiodexa Pharmaceuticals PLC
$1.22-2.40%
PGY Logo
PGYPagaya Technologies Ltd
$12.62-%
RDHL Logo
RDHLRedhill Biopharma Ltd
$1.044.00%
RILY Logo
RILYBRC Group Holdings Inc
$7.15-%
Comments
Loading...